Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
FibroBiologics Inc. (NASDAQ : FBLG) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc.
Quote
| Last: | $1 |
|---|---|
| Change Percent: | -3.85% |
| Open: | $1.07 |
| Close: | $1.04 |
| High: | $1.07 |
| Low: | $0.9899 |
| Volume: | 38,640 |
| Last Trade Date Time: | 06/05/2026 12:43:47 pm |
Stock Data
| Market Cap: | $17,774,070 |
|---|---|
| Float: | 39,126,900 |
| Insiders Ownership: | 0.21% |
| Institutions: | 18 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.fibrobiologics.com |
| Country: | US |
| City: | Houston |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about FibroBiologics Inc. (NASDAQ: FBLG).
